Decision: Favourable
Study Title:
A Multicenter, Open-label Extension (OLE) Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE004 in Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)
NREC Code:
23-NREC-CT-026
Decision:
Favourable
Meeting Date:
24/03/2023
Study Type:
CT application
Principal Investigator:
Prof Orla Hardiman
PI Institution:
St. James's Hospital, Dublin
Sponsor:
Wave Life Sciences